<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-520" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Schamberg Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zaldivar Fujigaki</surname>
            <given-names>Jose L.</given-names>
          </name>
          <aff>National Medical Center 20 de Noviembre, ISSSTE</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anjum</surname>
            <given-names>Fatima</given-names>
          </name>
          <aff>Temple University, Lewis Katz School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jose Zaldivar Fujigaki declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fatima Anjum declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-520.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Schamberg disease is the most frequent purpuric of the dermatoses, with a classical presentation characterized by petechiae, purpura, and increased skin pigmentation. It is a benign and chronic condition, although idiopathic in origin, the diagnosis is not a dilemma since it is mainly made by inspections and identification of classic morphology of the lesions. The biopsy is required to rule out mycosis fungoides. This activity highlights the role of the interprofessional team in the evaluation and treatment of Schamberg disease.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describes the etiology of Schamberg disease.</p></list-item><list-item><p>Outline the typical morphology of the lesions in Schamberg disease.</p></list-item><list-item><p>Identify the available treatment options for Schamberg disease.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=520&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=520">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-520.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Schamberg disease represents the most common type of pigmented purpuric dermatoses (PPDs), a chronic, benign, cutaneous eruptions characterized by petechiae, purpura, and increased skin pigmentation (brown, red, or yellow patchy).&#x000a0;The PPDs are grouped into five clinical entities: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura and, eczematoid-like purpura of Doucas and Kapetanakis.<xref ref-type="bibr" rid="article-520.r1">[1]</xref></p>
        <p>Schamber disease (SD) has also been called: progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressive and, Schamberg's purpura.<xref ref-type="bibr" rid="article-520.r2">[2]</xref>&#x000a0;It is commonly seen in males and mainly affects&#x000a0;the tibial regions, and could involve thighs, buttocks, trunk, or upper extremities.<xref ref-type="bibr" rid="article-520.r3">[3]</xref></p>
      </sec>
      <sec id="article-520.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The exact cause of Schamberg disease is not known. It is caused by extravasation of blood vessels particularly capillaries which allow red blood cells to get deposited into the skin which then releases their iron from hemoglobin. This iron causes a rust color accounting for the orange or brown tint of the rash.<xref ref-type="bibr" rid="article-520.r4">[4]</xref></p>
        <p>The exact cause of capillary inflammation is unknown and can be multifactorial. Potential contributors in the etiology can be:</p>
        <list list-type="order">
          <list-item>
            <p>Gravitational dependency<xref ref-type="bibr" rid="article-520.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Alcohol intake<xref ref-type="bibr" rid="article-520.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Drugs such as acetaminophen, aspirin, adalin, amlodipine, carbromal, chlordiazepoxide, glipizide, glybuzole, hydralazine, meprobamate, nitroglycerin, persantin, reserpine, thiamine, interferon-alfa, injection medroxyprogesterone acetate, topical fluorouracil, and sildenafil<xref ref-type="bibr" rid="article-520.r7">[7]</xref><xref ref-type="bibr" rid="article-520.r8">[8]</xref><xref ref-type="bibr" rid="article-520.r9">[9]</xref><xref ref-type="bibr" rid="article-520.r10">[10]</xref><xref ref-type="bibr" rid="article-520.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Genetic causes, as cases are seen in family members<xref ref-type="bibr" rid="article-520.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Hepatitis B antigenemia<xref ref-type="bibr" rid="article-520.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Dysfunctional immune system<xref ref-type="bibr" rid="article-520.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Idiopathic<xref ref-type="bibr" rid="article-520.r5">[5]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-520.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>PPDs include a spectrum of vascular diseases with an incidence of 0.18% of all skin diseases reported by Sharma and Gupta.<xref ref-type="bibr" rid="article-520.r14">[14]</xref>&#x000a0;SD is the most common&#x000a0;of the PPDs. It occurs in all races and ages ranging from 8 to 66 years (mean age 34 years), although a 19 month-old child has been reported.<xref ref-type="bibr" rid="article-520.r1">[1]</xref><xref ref-type="bibr" rid="article-520.r14">[14]</xref>&#x000a0;It has a male preponderance, having M&#x000a0;to F&#x000a0;ratio between 5&#x000a0;and 3.8&#x000a0;to 1.<xref ref-type="bibr" rid="article-520.r14">[14]</xref>&#x000a0;SD occurs more frequently in men, while purpura annularis telangiectodes of Majocchi occurs more frequently in females.&#x000a0;Lichen aureus and Majocchi diseases occur commonly in children or young adults, while dermatosis of Gougerot and Blum affects middle-aged and older men.<xref ref-type="bibr" rid="article-520.r1">[1]</xref><xref ref-type="bibr" rid="article-520.r4">[4]</xref><xref ref-type="bibr" rid="article-520.r14">[14]</xref></p>
      </sec>
      <sec id="article-520.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The main pathophysiological mechanism is the extravasation of red blood cells and the deposition of hemosiderin in macrophages.<xref ref-type="bibr" rid="article-520.r1">[1]</xref>&#x000a0;There are indicators that exhibit the role of the cell-mediated immunity in the pathology, with a T-cell lymphocytic infiltrate perivascularly.<xref ref-type="bibr" rid="article-520.r4">[4]</xref>&#x000a0;It has been suggested that medications act as haptens inducing the formation of antibody-antigen complexes.<xref ref-type="bibr" rid="article-520.r15">[15]</xref></p>
        <p>Reactive oxygen species generate inflammation, edema, and damage in the structure and function of the endothelial barrier, causing increased capillary permeability.<xref ref-type="bibr" rid="article-520.r16">[16]</xref>&#x000a0;Various aggravating factors include hypertension, diabetes mellitus, venous stasis, strenuous exercise, gravitational dependency, capillary fragility, infections, and chemical ingestion has been related.<xref ref-type="bibr" rid="article-520.r1">[1]</xref></p>
      </sec>
      <sec id="article-520.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathology shows perivascular T-cell lymphocytic infiltrate around superficial small blood vessels composed of CD3+, CD4+, CD8+, CD1a+, CD36+, dendritic cells, cellular adhesion molecules (ICAM-1, ELAM-1), LFA-1; this infiltrate consequently will lead to endothelial cell swelling and narrowing of the lumen.<xref ref-type="bibr" rid="article-520.r4">[4]</xref><xref ref-type="bibr" rid="article-520.r17">[17]</xref></p>
        <p>Extravasation of red blood cells with marked hemosiderin deposition in macrophage is present in the superficial dermis, which can be seen by an iron stain.<xref ref-type="bibr" rid="article-520.r4">[4]</xref></p>
      </sec>
      <sec id="article-520.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Schamberg disease is usually asymptomatic but can occasionally be itchy or painful. Many times, lesions resolve spontaneously. It is a chronic disease with different stages at the same time, while some are appearing older lesions will fade.<xref ref-type="bibr" rid="article-520.r3">[3]</xref></p>
        <p>Lesions are characterized by irregular localized well-circumscribed red, orange to brown or yellow non-bleachable patches pinhead-sized cayenne pepper spots of varying shapes and size in the form of multiple papules and macules beginning from the lower legs which gradually spreads in an ascending pattern to the rest of the body. The most common site affected is the bilateral lower extremities, thighs and buttocks are also frequently involved. Less commonly, it involves upper extremity or can be generalized.<xref ref-type="bibr" rid="article-520.r4">[4]</xref><xref ref-type="bibr" rid="article-520.r18">[18]</xref></p>
      </sec>
      <sec id="article-520.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis is usually made by clinical inspection and identification of the classic morphology of the lesions. Although a biopsy is not mandatory, it is useful to rule out differential diagnoses.</p>
        <p>Capillary fragility can be assessed by the Hess&#x02019;s or Rumpel-Leede test, also called a tourniquet test. For this test, the pressure is applied to the forearm with a blood pressure cuff inflated between systolic and diastolic blood pressure for 5 to 10 minutes. After removing the cuff, fifteen or more petechiae in a 5 cm diameter area indicates capillary fragility. It occurs due to poor platelet function.<xref ref-type="bibr" rid="article-520.r19">[19]</xref></p>
        <p>Dermoscopy is a diagnostic tool to examine the skin using a special magnifying lens. In SD it shows coppery-red pigmentation as the most common finding in 97%, followed by red globules in 75%, then red dots (69%), brown dots (53%), reticular network (34%), red patch (34%), brown globules (26%), and linear vessels (22%).<xref ref-type="bibr" rid="article-520.r20">[20]</xref></p>
        <p>No laboratory abnormalities are associated with SD although a complete blood count and peripheral blood smear are necessary to exclude infection and thrombocytopenia, coagulation screening helps to exclude other possible causes of purpura; other recommended tests are bleeding time, platelet aggregation function, ANA, RF, anti-HBsAg antibody and anti-HCV antibody.<xref ref-type="bibr" rid="article-520.r20">[20]</xref></p>
        <p>Skin biopsy: Histopathology shows perivascular T-cell lymphocytic infiltrate around superficial small blood vessels, extravasation of red blood cells with marked hemosiderin deposition in macrophage in the superficial dermis.<xref ref-type="bibr" rid="article-520.r4">[4]</xref></p>
      </sec>
      <sec id="article-520.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Schamberg disease is still considered idiopathic. Without an established therapy, treatment is sometimes ineffective, and recurrences are not uncommon. It is not life-threatening or causes any major health concern. Reassurance about the chronic and benign nature of the disease is required, and residual pigmentation could last for years.<xref ref-type="bibr" rid="article-520.r4">[4]</xref></p>
        <p>First-line interventions are nonpharmacologic interventions and topical steroids. Various non-drug strategies are aimed at eliminating or reducing potential contributing factors such as discontinuing or changing the offending medication, avoiding food preservatives and artificial coloring agents, and wearing support stockings to counteract abnormal vein function.</p>
        <p>The itching will improve with moisturizing, oral antihistamines, and topical steroids, such as cortisone or betamethasone, may be used. Topical steroids decrease inflammation by suppressing the migration of polymorphonuclear leukocytes and reversing capillary permeability.<xref ref-type="bibr" rid="article-520.r4">[4]</xref>&#x000a0;The use of anti-inflammatory drugs is used to treat skin diseases&#x000a0;by&#x000a0;immune mediation.<xref ref-type="bibr" rid="article-520.r21">[21]</xref></p>
        <p>Second-line&#x000a0;intervention: Pentoxifylline, a methylxanthine derivative, acts by various mechanisms.</p>
        <list list-type="order">
          <list-item>
            <p>Potent rheological and anti-inflammatories properties.<xref ref-type="bibr" rid="article-520.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p>Immunomodulatory action by modifying cytokine profile and anti-fibroblastic action.<xref ref-type="bibr" rid="article-520.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p>A decrease in expression of ICAM-I on endothelial cells of blood vessels that leads to decreased exudation of inflammatory cells from capillaries into the surrounding perivascular tissue.<xref ref-type="bibr" rid="article-520.r23">[23]</xref><xref ref-type="bibr" rid="article-520.r24">[24]</xref></p>
          </list-item>
          <list-item>
            <p>Inhibits synthesis and release of TNF-a, which also reduces the extravasation of blood from the capillaries.<xref ref-type="bibr" rid="article-520.r23">[23]</xref></p>
          </list-item>
        </list>
        <p>Different clinical trials reported a clinical improvement from the 2-3 weeks until six months, with doses ranging from 100-400 mg three times a day.<xref ref-type="bibr" rid="article-520.r22">[22]</xref><xref ref-type="bibr" rid="article-520.r23">[23]</xref></p>
        <p>Phototherapy had shown to be effective in a few case reports. Most of these were resistant to other therapies. Narrowband ultraviolet B therapy-induced immunomodulation by suppression of the interleukin-2 production and altering the T cells activity. It was used in two children and one adult two-three times a week for 10-20 treatments with improvement and without recurrence during the follow-up.<xref ref-type="bibr" rid="article-520.r25">[25]</xref><xref ref-type="bibr" rid="article-520.r26">[26]</xref>&#x000a0;Although it was effective in an adult, the treatment should be continued for a long period.<xref ref-type="bibr" rid="article-520.r27">[27]</xref></p>
        <p>PUVA phototherapy diminished the CD4+ and CD1a+ cells and the adhesion molecule receptor and had proved to be effective in eight patients.<xref ref-type="bibr" rid="article-520.r28">[28]</xref><xref ref-type="bibr" rid="article-520.r29">[29]</xref><xref ref-type="bibr" rid="article-520.r30">[30]</xref>&#x000a0;Intense pulse laser (IPL) acts through the absorption by the hemoglobin in the vessels generating thermal damage. The Advanced Fluorescence Technology, a new generation of IPL, selectively targets hemosiderin within macrophages and hemoglobin within extravasated erythrocytes shown to be effective in 5 patients.<xref ref-type="bibr" rid="article-520.r31">[31]</xref></p>
        <p>Multiple other therapies have been utilized for SD, although only a few of them have been effective.</p>
        <p>Ascorbic acid and bioflavonoids have additive antioxidative properties that wield an angio-protective and anti-inflammatory effect. It also decreases the permeability of endothelial cells and reduces capillary permeability and fragility by increasing their resistance. Three patients were treated with 500 mg bid and 50 mg bid, respectively, with clinical improvement at four weeks.<xref ref-type="bibr" rid="article-520.r16">[16]</xref></p>
        <p>Colchicine 0.5 g bid has been used with the improvement from the first week to complete clearance by the four months.<xref ref-type="bibr" rid="article-520.r32">[32]</xref><xref ref-type="bibr" rid="article-520.r33">[33]</xref>&#x000a0;Aminaphtone helps reduce capillary fragility, and red blood cell leakage reported improvement with 75mg bid for one month without recurrence for one year after suspended.<xref ref-type="bibr" rid="article-520.r34">[34]</xref>&#x000a0;Griseofulvin could have an immunomodulatory activity improving the SD at a dose of 500-750 mg since the first week.<xref ref-type="bibr" rid="article-520.r35">[35]</xref>&#x000a0;Variable results are found with other drugs, also like oral cyclosporin, calcineurin-inhibitors, methotrexate.<xref ref-type="bibr" rid="article-520.r24">[24]</xref><xref ref-type="bibr" rid="article-520.r4">[4]</xref><xref ref-type="bibr" rid="article-520.r36">[36]</xref></p>
      </sec>
      <sec id="article-520.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis should be made with other cutaneous lesions that may present with petechiae, purpura, or localized hyperpigmentation related to hemosiderin deposition such as other DPPs.</p>
        <p>Purpura annularis telangiectodes (Majocci disease), is characterized by annular, purpuric lesions and erythematous punctate lesions, and central clearing with slight atrophy.</p>
        <p>Touraine, a variant of Majocci&#x02019;s Disease, exhibits a purpura telangiectatic arciform, with fewer lesions, larger, and irregularly arciform.<xref ref-type="bibr" rid="article-520.r4">[4]</xref></p>
        <p>Pigmented purpuric dermatosis of Gougerot and Blum is characterized by red-brown lichenoid papules that tend to fuse in plaques in older men.<xref ref-type="bibr" rid="article-520.r4">[4]</xref><xref ref-type="bibr" rid="article-520.r3">[3]</xref></p>
        <p>Eczematoid like purpura of Doucas and Kapetanakis is usually bilateral, intensely itchy, and characteristically has eczematous features. Mild lichenification could be present and has a fluctuation course with spontaneous improvement occasionally.<xref ref-type="bibr" rid="article-520.r4">[4]</xref><xref ref-type="bibr" rid="article-520.r37">[37]</xref></p>
        <p>Stasis dermatitis exhibits eczematous patches that progress to red-brown or brownish colored irregular patches, associated varicosities, and leg edema, although both entities could coexist.<xref ref-type="bibr" rid="article-520.r38">[38]</xref></p>
        <p>Leukocytoclastic vasculitis hemorrhagic bullae and brown pigmentation consistent with hemosiderin deposits, the palpable nature of the lesions, and the histopathology report differentiate it from SD.<xref ref-type="bibr" rid="article-520.r39">[39]</xref></p>
        <p>Nonaccidental injury exhibit a purpuric patch that evolves and resolves in a few weeks.</p>
        <p>Mycosis fungoides can be challenging to distinguish from SD, histopathology detection in the epidermis of large groups of lymphocytes, or many lymphocytes in the spinous layer favor mycosis fungoides.<xref ref-type="bibr" rid="article-520.r40">[40]</xref></p>
        <p>Scurvy purpuric lesions could be confused, other features in scurvy such as perifollicular purpura, coiled hairs, bleeding gums, and dietary history of reduced vitamin C intake supports scurvy.<xref ref-type="bibr" rid="article-520.r41">[41]</xref></p>
        <p>Drug hypersensitivity reactions due to rituximab, carbamazepine, meprobamate, bufexamac, chlordiazepoxide, furosemide, nitroglycerin, vitamin B-1, or medroxyprogesterone acetate.<xref ref-type="bibr" rid="article-520.r4">[4]</xref></p>
      </sec>
      <sec id="article-520.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The course of the condition is typically chronic, with numerous exacerbations and remissions. Lesions could persist or extend with time and spontaneous resolution also may occur in a period ranging from months to years. Ratnam et al reported in a series of cases&#x000a0;in which 62% of the patients cleared entirely while 38% remained stable or experienced worsening of their symptoms.<xref ref-type="bibr" rid="article-520.r4">[4]</xref><xref ref-type="bibr" rid="article-520.r5">[5]</xref></p>
      </sec>
      <sec id="article-520.s12" sec-type="Complications">
        <title>Complications</title>
        <p>In general, SD is a benign condition, although it&#x000a0;can cause worsening and recurrent chronic skin lesions, resistant to treatment.</p>
        <p>There are infrequent reports of patients with SD that developed mycosis fungoides presented as SD. Clinical and histopathological properties shared some similarities. Although it is rare&#x000a0;to develop mycosis fungoides after an initial diagnosis of SD this could be suspected when has a long-lasting course (&#x0003e;1 year), and follow-up could be made every year.<xref ref-type="bibr" rid="article-520.r42">[42]</xref></p>
        <p>Emotional stress and psychological trauma can come due to the longstanding pigmentation in the skin leading to depression and anxiety in some patients.</p>
      </sec>
      <sec id="article-520.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Leg elevation is advised.</p>
        <p>Venous stasis should be controlled with a compression bandage.</p>
        <p>Prolonged leg dependency should be avoided.</p>
        <p>Patients are advised to avoid precipitating factors like any food or food additives with preservatives and artificial colors.</p>
      </sec>
      <sec id="article-520.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Schamberg disease represents one of the most common types of pigmented purpuric dermatoses diagnosis is usually made by clinical inspection, although a biopsy is always useful for differential diagnosis, it is not mandatory. The exact cause of Shamberg&#x000b4;s disease is not known. T-cell mediated immunity plays an important role in the pathology; there is also a multifactorial component including gravitational dependency, alcohol intake, drugs, a genetic component, hepatitis B antigenemia, and dysfunctional immune system. This type of purpuric dermatoses affects all races and usually affects older adults with a male preponderance.</p>
        <p>While Schamberg disease usually does not represent a diagnostic dilemma, treatment does. Since there is not an established therapy, the options are wide, such as topical steroids, phototherapy, pentoxifylline, colchicine, oral cyclosporine, griseofulvin, ascorbic acid, and other infrequent treatments. Among them, phototherapy has been considered in patients who fail topical therapy, even though larger studies are required to confirm phototherapy as a promising therapy. Although the treatment variety is wide, the expert opinion from the specialist is useful to select the appropriate therapy.</p>
        <p>Differential diagnosis is crucial and is mainly depends upon thorough clinical inspection and identification of classic morphology. The histopathology plays a vital role in differentiating from mycosis fungoides. Although this is a benign disease, numerous exacerbations and spontaneous resolution can be discouraging in some patients. The residual pigmentation could induce depression and anxiety in patients. Therefore, psychological support is crucial in these circumstances.</p>
        <p>The outcomes in Schamberg disease is usually good. There could be relapses, and the treatments could be extended even for years, therefore keeping the patient motivated is crucial to complete the treatment.</p>
      </sec>
      <sec id="article-520.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=520&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=520">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/schamberg-disease-progressive-pigmentary-dermatosis-of-schamberg-purpura-pigmentosa-progressive-and-schambergs-purpura/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=520">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/520/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=520">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-520.s16">
        <title>References</title>
        <ref id="article-520.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zvulunov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Avinoach</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hatskelzon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Halevy</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pigmented purpuric dermatosis (Schamberg's purpura) in an infant.</article-title>
            <source>Dermatol Online J</source>
            <year>1999</year>
            <month>May</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <pub-id pub-id-type="pmid">10673445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>RANDALL</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>KIERLAND</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>MONTGOMERY</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pigmented purpuric eruptions.</article-title>
            <source>AMA Arch Derm Syphilol</source>
            <year>1951</year>
            <month>Aug</month>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>177</fpage>
            <page-range>177-91</page-range>
            <pub-id pub-id-type="pmid">14856408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tristani-Firouzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Meadows</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Vanderhooft</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pigmented purpuric eruptions of childhood: a series of cases and review of literature.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2001</year>
            <season>Jul-Aug</season>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>299</fpage>
            <page-range>299-304</page-range>
            <pub-id pub-id-type="pmid">11576402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sardana</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sarkar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sehgal</surname>
                <given-names>VN</given-names>
              </name>
            </person-group>
            <article-title>Pigmented purpuric dermatoses: an overview.</article-title>
            <source>Int J Dermatol</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>43</volume>
            <issue>7</issue>
            <fpage>482</fpage>
            <page-range>482-8</page-range>
            <pub-id pub-id-type="pmid">15230884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ratnam</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Purpura simplex (inflammatory purpura without vasculitis): a clinicopathologic study of 174 cases.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1991</year>
            <month>Oct</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>642</fpage>
            <page-range>642-7</page-range>
            <pub-id pub-id-type="pmid">1791222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonnet</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Selle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Isbruch</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Isbruch</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Recurrent purpura due to alcohol-related Schamberg's disease and its association with serum immunoglobulins: a longitudinal observation of a heavy drinker.</article-title>
            <source>J Med Case Rep</source>
            <year>2016</year>
            <month>Oct</month>
            <day>31</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>301</fpage>
            <pub-id pub-id-type="pmid">27799068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ko&#x000e7;ak</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Akay</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Heper</surname>
                <given-names>AO</given-names>
              </name>
            </person-group>
            <article-title>Sildenafil-induced pigmented purpuric dermatosis.</article-title>
            <source>Cutan Ocul Toxicol</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>91</fpage>
            <page-range>91-2</page-range>
            <pub-id pub-id-type="pmid">22780873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Voelter</surname>
                <given-names>WW</given-names>
              </name>
            </person-group>
            <article-title>Pigmented purpuric dermatosis-like reaction to topical fluorouracil.</article-title>
            <source>Arch Dermatol</source>
            <year>1983</year>
            <month>Nov</month>
            <volume>119</volume>
            <issue>11</issue>
            <fpage>875</fpage>
            <page-range>875-6</page-range>
            <pub-id pub-id-type="pmid">6685460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schetz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Koci&#x00107;</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>A new adverse drug reaction--Schamberg's disease caused by amlodipine administration--a case report.</article-title>
            <source>Br J Clin Pharmacol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>80</volume>
            <issue>6</issue>
            <fpage>1477</fpage>
            <page-range>1477-8</page-range>
            <pub-id pub-id-type="pmid">26256559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishioka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Katayama</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Masuzawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yokozeki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nishiyama</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced chronic pigmented purpura.</article-title>
            <source>J Dermatol</source>
            <year>1989</year>
            <month>Jun</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>220</fpage>
            <page-range>220-2</page-range>
            <pub-id pub-id-type="pmid">2507607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abeck</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Kuwert</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Steinkraus</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mensing</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ring</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Acetaminophen-induced progressive pigmentary purpura (Schamberg's disease).</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1992</year>
            <month>Jul</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>123</fpage>
            <page-range>123-4</page-range>
            <pub-id pub-id-type="pmid">1619063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kanwar</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Thami</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>Familial Schamberg's disease.</article-title>
            <source>Dermatology</source>
            <year>1999</year>
            <volume>198</volume>
            <issue>2</issue>
            <fpage>175</fpage>
            <page-range>175-6</page-range>
            <pub-id pub-id-type="pmid">10325471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aiba</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tagami</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Immunohistologic studies in Schamberg's disease. Evidence for cellular immune reaction in lesional skin.</article-title>
            <source>Arch Dermatol</source>
            <year>1988</year>
            <month>Jul</month>
            <volume>124</volume>
            <issue>7</issue>
            <fpage>1058</fpage>
            <page-range>1058-62</page-range>
            <pub-id pub-id-type="pmid">3291778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinicoepidemiological study of pigmented purpuric dermatoses.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-20</page-range>
            <pub-id pub-id-type="pmid">23130254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adams</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Gadenne</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Glipizide-induced pigmented purpuric dermatosis.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1999</year>
            <month>Nov</month>
            <volume>41</volume>
            <issue>5 Pt 2</issue>
            <fpage>827</fpage>
            <page-range>827-9</page-range>
            <pub-id pub-id-type="pmid">10534660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reinhold</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Seiter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ugurel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tilgen</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Treatment of progressive pigmented purpura with oral bioflavonoids and ascorbic acid: an open pilot study in 3 patients.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1999</year>
            <month>Aug</month>
            <volume>41</volume>
            <issue>2 Pt 1</issue>
            <fpage>207</fpage>
            <page-range>207-8</page-range>
            <pub-id pub-id-type="pmid">10426890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghersetich</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lotti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bacci</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Comacchi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Campanile</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Romagnoli</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Cell infiltrate in progressive pigmented purpura (Schamberg's disease): immunophenotype, adhesion receptors, and intercellular relationships.</article-title>
            <source>Int J Dermatol</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>34</volume>
            <issue>12</issue>
            <fpage>846</fpage>
            <page-range>846-50</page-range>
            <pub-id pub-id-type="pmid">8647662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kerem</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Branski</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gross-Kieselstein</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hurvitz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Abrahamov</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Chronic pigmented purpura: a case report of Schamberg's disease.</article-title>
            <source>Clin Pediatr (Phila)</source>
            <year>1987</year>
            <month>Dec</month>
            <volume>26</volume>
            <issue>12</issue>
            <fpage>657</fpage>
            <page-range>657-8</page-range>
            <pub-id pub-id-type="pmid">3677535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lava</surname>
                <given-names>SAG</given-names>
              </name>
              <name>
                <surname>Milani</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Fossali</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Simonetti</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Agostoni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bianchetti</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous Manifestations of Small-Vessel Leukocytoclastic Vasculitides in Childhood.</article-title>
            <source>Clin Rev Allergy Immunol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>53</volume>
            <issue>3</issue>
            <fpage>439</fpage>
            <page-range>439-451</page-range>
            <pub-id pub-id-type="pmid">28836099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ozkaya</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Emiroglu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Cengiz</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Bahali</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Yildiz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Demirkesen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Onsun</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Dermatoscopic findings of pigmented purpuric dermatosis.</article-title>
            <source>An Bras Dermatol</source>
            <year>2016</year>
            <season>Sep-Oct</season>
            <volume>91</volume>
            <issue>5</issue>
            <fpage>584</fpage>
            <page-range>584-587</page-range>
            <pub-id pub-id-type="pmid">27828629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mukkamala</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Baban</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Krishnaswamy</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Persistent urticarial eruption in an asthmatic patient.</article-title>
            <source>Ann Allergy Asthma Immunol</source>
            <year>1996</year>
            <month>Nov</month>
            <volume>77</volume>
            <issue>5</issue>
            <fpage>359</fpage>
            <page-range>359-64</page-range>
            <pub-id pub-id-type="pmid">8933773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Panda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Malakar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lahiri</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Oral pentoxifylline vs topical betamethasone in Schamberg disease: a comparative randomized investigator-blinded parallel-group trial.</article-title>
            <source>Arch Dermatol</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>140</volume>
            <issue>4</issue>
            <fpage>491</fpage>
            <page-range>491-3</page-range>
            <pub-id pub-id-type="pmid">15096387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hirayama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Orihara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shiohara</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of Schamberg's disease with pentoxifylline.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1997</year>
            <month>May</month>
            <volume>36</volume>
            <issue>5 Pt 2</issue>
            <fpage>827</fpage>
            <page-range>827-30</page-range>
            <pub-id pub-id-type="pmid">9146559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoesly</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Huerter</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Shehan</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Purpura annularis telangiectodes of Majocchi: case report and review of the literature.</article-title>
            <source>Int J Dermatol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>48</volume>
            <issue>10</issue>
            <fpage>1129</fpage>
            <page-range>1129-33</page-range>
            <pub-id pub-id-type="pmid">19775410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Can</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Turkoglu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Kavala</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zindanci</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kural</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of generalized childhood Schamberg's disease with narrowband ultraviolet B therapy.</article-title>
            <source>Photodermatol Photoimmunol Photomed</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>216</fpage>
            <page-range>216-8</page-range>
            <pub-id pub-id-type="pmid">21729171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gudi</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>MI</given-names>
              </name>
            </person-group>
            <article-title>Progressive pigmented purpura (Schamberg's disease) responding to TL01 ultraviolet B therapy.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>683</fpage>
            <page-range>683-4</page-range>
            <pub-id pub-id-type="pmid">15550157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lasocki</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>RI</given-names>
              </name>
            </person-group>
            <article-title>Narrowband UVB therapy as an effective treatment for Schamberg's disease.</article-title>
            <source>Australas J Dermatol</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>49</volume>
            <issue>1</issue>
            <fpage>16</fpage>
            <page-range>16-8</page-range>
            <pub-id pub-id-type="pmid">18186840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Ratnam</surname>
                <given-names>KV</given-names>
              </name>
            </person-group>
            <article-title>A report of two cases of pigmented purpuric dermatoses treated with PUVA therapy.</article-title>
            <source>Acta Derm Venereol</source>
            <year>1991</year>
            <volume>71</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-70</page-range>
            <pub-id pub-id-type="pmid">1676222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lotti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ghersetich</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Panconesi</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Why should we use PUVA treatment in pigmented purpuric lichenoid dermatitis?</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1994</year>
            <month>Jan</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>145</fpage>
            <pub-id pub-id-type="pmid">7506273</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seckin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yazici</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Senol</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Demircay</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>A case of Schamberg's disease responding dramatically to PUVA treatment.</article-title>
            <source>Photodermatol Photoimmunol Photomed</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>95</fpage>
            <page-range>95-6</page-range>
            <pub-id pub-id-type="pmid">18353090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manolakos</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Glick</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Schamberg's disease with advanced fluorescence technology.</article-title>
            <source>J Drugs Dermatol</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>528</fpage>
            <page-range>528-9</page-range>
            <pub-id pub-id-type="pmid">22453593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geller</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Benefit of colchicine in the treatment of Schamberg's disease.</article-title>
            <source>Ann Allergy Asthma Immunol</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>85</volume>
            <issue>3</issue>
            <fpage>246</fpage>
            <pub-id pub-id-type="pmid">11030283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cavalcante</surname>
                <given-names>MLLL</given-names>
              </name>
              <name>
                <surname>Masuda</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Brito</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>ACVD</given-names>
              </name>
              <name>
                <surname>Itimura</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nunes</surname>
                <given-names>AJF</given-names>
              </name>
            </person-group>
            <article-title>Schamberg's disease: case report with therapeutic success by using colchicine.</article-title>
            <source>An Bras Dermatol</source>
            <year>2017</year>
            <season>Mar-Apr</season>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>246</fpage>
            <page-range>246-248</page-range>
            <pub-id pub-id-type="pmid">28538889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Godoy</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Batig&#x000e1;lia</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Aminaphtone in the control of Schamberg's disease.</article-title>
            <source>Thromb J</source>
            <year>2009</year>
            <month>Jun</month>
            <day>11</day>
            <volume>7</volume>
            <fpage>8</fpage>
            <pub-id pub-id-type="pmid">19515261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tamaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yasaka</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Osada</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shibagaki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Furue</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of pigmented purpuric dermatosis with griseofulvin.</article-title>
            <source>Br J Dermatol</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>132</volume>
            <issue>1</issue>
            <fpage>159</fpage>
            <page-range>159-60</page-range>
            <pub-id pub-id-type="pmid">7756136</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Miyachi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Purpura pigmentosa chronica successfully treated with oral cyclosporin A.</article-title>
            <source>Br J Dermatol</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>134</volume>
            <issue>1</issue>
            <fpage>180</fpage>
            <page-range>180-1</page-range>
            <pub-id pub-id-type="pmid">8745912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DOUCAS</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>KAPETANAKIS</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Eczematid-like purpura.</article-title>
            <source>Dermatologica</source>
            <year>1953</year>
            <volume>106</volume>
            <issue>2</issue>
            <fpage>86</fpage>
            <page-range>86-95</page-range>
            <pub-id pub-id-type="pmid">13060054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sundaresan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Migden</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Silapunt</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Stasis Dermatitis: Pathophysiology, Evaluation, and Management.</article-title>
            <source>Am J Clin Dermatol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>383</fpage>
            <page-range>383-390</page-range>
            <pub-id pub-id-type="pmid">28063094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carlson</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>The histological assessment of cutaneous vasculitis.</article-title>
            <source>Histopathology</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-23</page-range>
            <pub-id pub-id-type="pmid">20055902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toro</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Sander</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>LeBoit</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Persistent pigmented purpuric dermatitis and mycosis fungoides: simulant, precursor, or both? A study by light microscopy and molecular methods.</article-title>
            <source>Am J Dermatopathol</source>
            <year>1997</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>108</fpage>
            <page-range>108-18</page-range>
            <pub-id pub-id-type="pmid">9129694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirschmann</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Raugi</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Adult scurvy.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>895</fpage>
            <page-range>895-906; quiz 907-10</page-range>
            <pub-id pub-id-type="pmid">10570371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-520.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lipsker</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cribier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Heid</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Grosshans</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>[Cutaneous lymphoma manifesting as pigmented, purpuric capillaries].</article-title>
            <source>Ann Dermatol Venereol</source>
            <year>1999</year>
            <month>Apr</month>
            <volume>126</volume>
            <issue>4</issue>
            <fpage>321</fpage>
            <page-range>321-6</page-range>
            <pub-id pub-id-type="pmid">10421934</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
